a public good project by the
Synthesis
Company
of California

© 2026

Gene G. Kinney | doi.page

0 works0 citations0 h-index

Gene G. Kinney

Prothena (United States)(US)

Publications by Year

Research Areas

Neuroscience and Neuropharmacology Research, Amyloidosis: Diagnosis, Treatment, Outcomes, Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Receptor Mechanisms and Signaling

Most-Cited Works

→ Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis(2012)500 cited
→ Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers(2007)417 cited
→ Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels(2001)309 cited
→ A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models(2005)299 cited
→ Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease(2018)285 cited
→ Selective activation of the M ₁ muscarinic acetylcholine receptor achieved by allosteric potentiation(2009)284 cited

→ First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers(2016)

244 cited

→ Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment(2003)237 cited

→ Metabotropic Glutamate Subtype 5 Receptors Modulate Locomotor Activity and Sensorimotor Gating in Rodents(2003)220 cited

→ First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction(2016)204 cited